Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurogen (NRGN) -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (269)	3/24/2000 7:32:00 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 523

Tisch continue to accumulate NRGN while insiders bailed out (options) in a big way. Nice combination! freeedgar.com Item 5. Interest in Securities of the Issuer. The following transactions were effected by the Reporting Persons during the sixty days preceding the date hereof. None of the Reporting Persons above effected any other transactions in the Common Stock during the 60 days preceding the date hereof. Transaction Market Date Security No. Price/Share ----------- ------ ------- --------- ---------- ------------ Purchase NASDAQ 2/9/00 Common 35,500 (1) $25.4472 Purchase NASDAQ 2/10/00 Common 14,200 (2) $28.0757 Purchase NASDAQ 2/16/00 Common 65,000 (3) $34.5577 (1) Includes 17,750 shares purchased by Baker-Tisch Investments and 17,750 shares purchased by Baker Bros. Investments. (2) Includes 7,100 shares purchased by Baker-Tisch Investments and 7,100 shares purchased by Baker Bros. Investments. (3) Includes 32,500 shares purchased by Baker-Tisch Investments and 32,500 shares purchased by Baker Bros. Investments. Set forth in the table below is the aggregate number of shares of Common Stock beneficially owned as of the date hereof by each Reporting Person, together with the percentage of outstanding shares of Common Stock which is beneficially owned by each such person or entity. Page 25 of 33 pages <PAGE> ------------------------- ------------------------- CUSIP No. 64124E 10 6 Page 26 of 33 Pages ------------------------- ------------------------- Name of Amount and Nature of % of Class Beneficial Owner Beneficial Ownership Outstanding Four Partners 488,800 3.3% Four-Fourteen Partners 300,000 2.0% Andrew Tisch GRAT II 346,940 2.3% Daniel Tisch GRAT II 346,940 2.3% James Tisch GRAT II 346,940 2.3% Thomas Tisch GRAT II 346,940 2.3% Andrew Tisch GRAT VI 111,943 0.8% Daniel Tisch GRAT VI 111,943 0.8% James Tisch GRAT VI 111,943 0.8% Thomas Tisch GRAT VI 111,943 0.8% Andrew Tisch 2000 GRAT IV 88,242 0.6% Daniel Tisch 2000 GRAT IV 88,242 0.6% James Tisch 2000 GRAT IV 88,242 0.6% Thomas Tisch 2000 GRAT IV 88,242 0.6% Baker-Tisch Investments, LLC 57,350 0.4% Baker Bros. Investments LLC 57,350 0.4% Julian C. Baker 209,400 (2) 1.4% Felix J. Baker 197,892 (2) 1.3% Total 3,211,392 21.7%